Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Int J Cancer. 2010 Nov 16;128(5):1240–1250. doi: 10.1002/ijc.25658

Figure 5.

Figure 5

(a) Schematic representation of in vivo experimental design. (b) Isolated pancreatic tumor weight showing superior therapeutic efficacy in the combination treatment group relative to untreated control group (*p < 0.05; **p < 0.01). (c) Frequency of metastatic tumors and size distribution between the different treatment groups. (d) Gel shift assay and Western blot analysis for NF-κB and antiapoptotic proteins, survivin, Bcl-xL and IAP, in randomly selected primary tumor tissue remnants form each experimental group.